ArticleJournal of bone and mineral metabolism2026
Factors associated with improved quality of life in severe osteoporosis: a post hoc analysis of JOINT-05.
Article in Journal of bone and mineral metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe goal of modern osteoporosis management is to prevent fractures and preserve patient quality of life (QOL). However, factors associated with changes in QOL during treatment, particularly for patients with severe osteoporosis, are not well understood. This study aimed to identify clinical and biochemical factors associated with the magnitude of QOL improvement in this high-risk population. MATERIALS AND
methodsThis was a post hoc analysis of data from the Japan Osteoporosis Intervention Trial-05 (JOINT-05). The analysis included 612 women with severe osteoporosis, with a mean age of 81.3 years. The primary endpoint was the change in the EuroQol-5 dimensions (EQ-5D) utility score over 72 weeks. Potential baseline factors included patient demographics, oral health status (number of remaining teeth), low back pain intensity (visual analog scale, VAS), and biochemical markers. Factors associated with QOL change were evaluated using exploratory regression analyses and a clinically informed multivariable linear regression model.
resultsFollowing the treatment period, mean QOL scores improved significantly. In the clinically informed multivariable model, baseline EQ-5D, number of remaining teeth, serum tartrate-resistant acid phosphatase 5b levels, and corrected urinary pentosidine levels were independently associated with the change in EQ-5D from baseline to 72 weeks.
conclusionThis study identified several clinical and biochemical factors associated with QOL improvement in patients undergoing treatment for severe osteoporosis. These findings suggest that baseline QOL, oral health status, and biochemical markers of bone turnover and bone quality may be associated with QOL improvement during osteoporosis treatment. Further studies are needed to validate these exploratory findings.
Indexed as
Identifiers
42836966What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.